Yunnan Botanee Bio-Technology Group saw the highest growth of 266% in patent filings and 499% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 42% and grants by 13%. GlobalData’s DataBook provides a comprehensive analysis of Yunnan Botanee Bio-Technology Group’s patent filings and grants. Buy the databook here.
Yunnan Botanee Bio-Technology Group has been focused on protecting inventions in China(CN) with 26 publications in Q4 2023
The China(CN) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The China(CN) patent Office are among the top ten patent offices where Yunnan Botanee Bio-Technology Group is filings its patents. Among the top granted patent authorities, Yunnan Botanee Bio-Technology Group has 100% of its grants in China(CN)
Patents related to health & wellness and meat & seafood alternatives lead Yunnan Botanee Bio-Technology Group's portfolio
Yunnan Botanee Bio-Technology Group has the highest number of patents in health & wellness followed by, meat & seafood alternatives and climate change. For health & wellness, nearly 43% of patents were filed and no patents were granted in Q4 2023.
Skincare related patents lead Yunnan Botanee Bio-Technology Group portfolio followed by cosmetics & toiletries, and anti-agers
Yunnan Botanee Bio-Technology Group has highest number of patents in skincare followed by cosmetics & toiletries, anti-agers, packaging, and make-up. For skincare, nearly 41% of patents were filed and 11% of patents were granted in Q4 2023.
For comprehensive analysis of Yunnan Botanee Bio-Technology Group's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.